Top

European Archives of Oto-Rhino-Laryngology

Published in:

01-09-2018 | Head & Neck

Differential expression of cyclooxygenase-2 and cyclin D1 in salivary gland tumors

Published in: European Archives of Oto-Rhino-Laryngology | Issue 9/2018

Abstract

Purpose

Salivary gland tumors are complex and have a great histomorphological diversity; more than 30 histological subtypes are currently described and the study of proteins that help understand and differentiate these tumors is essential. We aimed to analyze the immunoexpression of cyclooxygenase-2 (COX-2) and cyclin D1 proteins in pleomorphic adenomas (PA), mucoepidermoid carcinomas (MEC) and adenoid cystic carcinomas (AdCC) of salivary glands.

Methods

A total of 38 PA, 12 AdCC and 12 MEC underwent immunohistochemical study by the polymeric biotin-free technique. Immunopositive cells were analyzed semi-quantitatively. For statistical analysis, a significance level was set at p ≤ 0.05.

Results

Overall, these tumors were more prevalent in women (n = 37). The mean age of these patients was 58-year-old and the parotid gland was the most affected anatomic site (n = 33). All cases of AdCC and MEC showed immunopositivity to cyclin D1; however, 39.5% of the PAs were negative (p < 0.001). Regarding COX-2 immunoexpression, we observed that all cases of CME were positive, whereas 60.5% of the PA and 75% of the CAC analyzed were completely negative (p = 0.042).

Conclusions

The overexpression of COX-2, observed only in MEC, emphasizes that salivary gland tumors have different profiles. Cyclin D1 is more immunoexpressed in malignant tumors. Together, these immunohistochemical findings may be useful in differentiating the studied tumors.

Seethala RR, Stenman G (2017) Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: tumors of the salivary gland. Head Neck Pathol 11(1):55–67. https://doi.org/10.1007/s12105-017-0795-0 View ArticlePubMedPubMed Central
Valstar MH, de Ridder M, van den Broek EC, Stuiver MM, van Dijk BAC, van Velthuysen MLF, Balm AJM, Smeele LE (2017) Salivary gland pleomorphic adenoma in the Netherlands: a nationwide observational study of primary tumor incidence, malignant transformation, recurrence, and risk factors for recurrence. Oral Oncol 66:93–99. https://doi.org/10.1016/j.oraloncology.2017.01.004 View ArticlePubMed
Andisheh-Tadbir A, Dehghani-Nazhvani A, Ashraf MJ, Khademi B, Mirhadi H, Torabi-Ardekani S (2016) MTA1 expression in benign and malignant salivary gland tumors. Iran J Otorhinolaryngol 28:51–59PubMedPubMed Central
Jour G, West K, Ghali V, Shank D, Ephrem G, Wenig BM (2013) Differential expression of p16(INK4A) and cyclin D1 in benign and malignant salivary gland tumors: a study of 44 Cases. Head Neck Pathol 7(3):224–231. https://doi.org/10.1007/s12105-012-0417-9 View ArticlePubMedPubMed Central
John RR, Malathi N, Ravindran C, Anandan S (2017) Mini review: multifaceted role played by cyclin D1 in tumor behavior. Indian J Dent Res 28(2):187–192. https://doi.org/10.4103/ijdr.IJDR_697_16 View ArticlePubMed
Liu Y, Sun H, Hu M, Zhang Y, Chen S, Tighe S, Zhu Y (2017) The role of cyclooxygenase-2 in colorectal carcinogenesis. Clin Colorectal Cancer 16(3):165–172. https://doi.org/10.1016/j.clcc.2016.09.012 View ArticlePubMed
Pang LY, Hurst EA, Argyle DJ (2016) Cyclooxygenase-2: a role in cancer stem cell survival and repopulation of cancer cells during therapy. Stem Cells Int 2016:2048731View ArticlePubMedPubMed Central
Yang G, Deng Q, Fan W, Zhang Z, Xu P, Tang S, Wang P, Wang J, Yu M (2017) Cyclooxygenase-2 expression is positively associated with lymph node metastasis in nasopharyngeal carcinoma. PLoS One 12(3):e0173641. https://doi.org/10.1371/journal.pone.0173641 View ArticlePubMedPubMed Central
Xu F, Li M, Zhang C, Cui J, Liu J, Li J, Jiang H (2017) Clinicopathological and prognostic significance of COX-2 immunohistochemical expression in breast cancer: a meta-analysis. Oncotarget 8(4):6003–6012. https://doi.org/10.18632/oncotarget.13990 View ArticlePubMed
Liu B, Wen JK, Li BH, Fang XM, Wang JJ, Zhang YP, Shi CJ, Zhang DQ, Han M (2011) Celecoxib and acetylbritannilactone interact synergistically to suppress breast cancer cell growth via COX-2-dependent and -independent mechanisms. Cell Death Dis 2:e185. https://doi.org/10.1038/cddis.2011.64 View ArticlePubMedPubMed Central
Chae SW, Sohn JH, Kim DH, Choi YJ, Park YL, Kim K, Cho YH, Pyo JS, Kim JH (2011) Overexpressions of cyclin B1, cdc2, p16 and p53 in human breast cancer: the clinicopathologic correlations and prognostic implications. Yonsei Med J 52(3):445–453. https://doi.org/10.3349/ymj.2011.52.3.445 View ArticlePubMedPubMed Central
Lee EY, Kang JY, Kim KW (2015) Expression of cyclooxygenase-2, peroxiredoxin I, peroxiredoxin 6 and nuclear factor-κB in oral squamous cell carcinoma. Oncol Lett 10(5):3129–3136View ArticlePubMedPubMed Central
Solomon MC, Vidyasagar MS, Fernandes D, Guddattu V, Mathew M, Shergill AK, Carnelio S, Chandrashekar C (2016) The prognostic implication of the expression of EGFR, p53, cyclin D1, Bcl-2 and p16 in primary locally advanced oral squamous cell carcinoma cases: a tissue microarray study. Med Oncol 33(12):138View ArticlePubMed
Akrish S, Peled M, Ben-Izhak O, Nagler RM (2009) Malignant salivary gland tumors and cyclo-oxygenase-2: a histopathological and immunohistochemical analysis with implications on histogenesis. Oral Oncol 45(12):1044–1050. https://doi.org/10.1016/j.oraloncology.2009.07.016 View ArticlePubMed
Tian Z, Li L, Wang L, Hu Y, Li J (2010) Salivary gland neoplasms in oral and maxillofacial regions: a 23-year retrospective study of 6982 cases in an eastern Chinese population. Int J Oral Maxillofac Surg 39(3):235–242. https://doi.org/10.1016/j.ijom.2009.10.016 View ArticlePubMed
Gao M, Hao Y, Huang MX, Ma DQ, Chen Y, Luo HY, Gao Y, Cao ZQ, Peng X, Yu GY (2017) Salivary gland tumours in a northern Chinese population: a 50-year retrospective study of 7190 cases. Int J Oral Maxillofac Surg 46(3):343–349. https://doi.org/10.1016/j.ijom.2016.09.021 View ArticlePubMed
Bolat Kucukzeybek B, Vedat Bayoglu I, Kucukzeybek Y, Alacacioglu A, Yigit S, Akder Sari A, Akyol M, Oktay Tarhan M (2017) The prognostic significance of cyclin D1 expression in patients with triple-negative breast cancer. J BUON 22(4):947–952PubMed
Kumar B, Yadav A, Brown NV, Zhao S, Cipolla MJ, Wakely PE, Schmitt AC, Baiocchi RA, Teknos TN, Old M, Kumar P (2017) Nuclear PRMT5, cyclin D1 and IL-6 are associated with poor outcome in oropharyngeal squamous cell carcinoma patientsand is inversely associated with p16-status. Oncotarget 8(9):14847–14859. https://doi.org/10.18632/oncotarget.14682 View ArticlePubMedPubMed Central
Qu K, Wang Z, Fan H, Li J, Liu J, Li P, Liang Z, An H, Jiang Y, Lin Q, Dong X, Liu P, Liu C (2017) MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma. Cell Death Dis 8(2):e2603. https://doi.org/10.1038/cddis.2016.352 View ArticlePubMedPubMed Central
Jen J, Lin LL, Lo FY, Chen HT, Liao SY, Tang YA, Su WC, Salgia R, Hsu CL, Huang HC, Juan HF, Wang YC (2017) Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer. Oncogene 36(36):5219. https://doi.org/10.1038/onc.2017.203 View ArticlePubMedPubMed Central
Patel RS, Rose B, Bawdon H, Hong A, Lee CS, Fredericks S, Gao K, O’Brien CJ (2007) Cyclin D1 and p16 expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma of the parotid gland. Histopathology 51(5):691–696View Article
Hugo HJ, Saunders C, Ramsay RG, Thompson EW (2015) New insights on COX-2 in chronic inflammation driving breast cancer growth and metastasis. J Mammary Gland Biol Neoplasia 20(3–4):109–119. https://doi.org/10.1007/s10911-015-9333-4 View ArticlePubMed
Zhou X, Shi X, Ren K, Fan GT, Wu SJ, Zhao JN (2015) Celecoxib inhibits cell growth and modulates the expression of matrix metalloproteinases in human osteosarcoma MG-63 cell line. Eur Rev Med Pharmacol Sci 19(21):4087–4097PubMed
Kuźbicki Ł, Lange D, Stanek-Widera A, Chwirot BW (2016) Intratumoral expression of cyclooxygenase-2 (COX-2) is a negative prognostic marker for patients with cutaneous melanoma. Melanoma Res 26(5):448–456. https://doi.org/10.1097/CMR.0000000000000282 View ArticlePubMed
Whynott RM, Manahan P, Geisler JP (2016) Vascular endothelial growth factor (VEGF) and cyclooxygenase 2 (COX 2) immunostaining in ovarian cancer. Eur J Gynaecol Oncol 37(2):164–166PubMed
Wang D, Guo XZ, Li HY, Zhao JJ, Shao XD, Wu CY (2014) Prognostic significance of cyclooxygenase-2 protein in pancreatic cancer: a meta-analysis. Tumour Biol 35(10):10301–10307. https://doi.org/10.1007/s13277-014-2260-y View ArticlePubMed
Song J, Su H, Zhou YY, Guo LL (2014) Cyclooxygenase-2 expression is associated with poor overall survival of patients with gastric cancer: a meta-analysis. Dig Dis Sci 59(2):436–445. https://doi.org/10.1007/s10620-013-2917-1 View ArticlePubMed
Turk HM, Camci C, Sevinc A, Bukyukberber S, Sari I, Adli M (2012) Cyclooxygenase-2 expression is not a marker of poor survival in lung cancer. Asian Pac J Cancer Prev 13(1):315–318View ArticlePubMed
Lee JW, Park JH, Suh JH, Nam KH, Choe JY, Jung HY, Chae JY, Moon KC (2012) Cyclooxygenase-2 expression and its prognostic significance in clear cell renal cell carcinoma. Korean J Pathol 46(3):237–245. https://doi.org/10.4132/KoreanJPathol.2012.46.3.237 View ArticlePubMedPubMed Central
Cho NP, Han HS, Soh Y, Son HJ (2007) Overexpression of cyclooxygenase-2 correlates with cytoplasmic HuR expression in salivary mucoepidermoid carcinoma but not in pleomorphic adenoma. J Oral Pathol Med 36(5):297–303View ArticlePubMed
Shishodia S, Koul D, Aggarwal BB (2004) Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis. J Immunol 173:2011–2022View ArticlePubMed

Title: Differential expression of cyclooxygenase-2 and cyclin D1 in salivary gland tumors
Publication date: 01-09-2018
Published in: European Archives of Oto-Rhino-Laryngology / Issue 9/2018
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-018-5058-5

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Differential expression of cyclooxygenase-2 and cyclin D1 in salivary gland tumors

Abstract

Purpose

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2018

Predictable prosthesis length on a high-resolution CT scan before a stapedotomy

Odontogenic sinusitis involving the frontal sinus: is middle meatal antrostomy enough?

Perhaps consider transmeatal approach for microscopic myringoplasty

Cholesteatoma vs granulation tissue: a differential diagnosis by DWI-MRI apparent diffusion coefficient

Surgery of benign thyroid disease by ENT/head and neck surgeons and general surgeons: 233 cases of vocal fold paralysis in 3509 patients

Impact of anatomic origin of primary squamous cell carcinomas of the nasal cavity and ethmoidal sinus on clinical outcome